146117-95-5 Usage
General Description
(Piperidin-4-yloxy)-acetic acid methyl ester hydrochloride is a chemical compound that belongs to the class of esters. It is formed by the reaction between piperidin-4-yloxy-acetic acid and methyl alcohol, with the addition of hydrochloric acid. (PIPERIDIN-4-YLOXY)-ACETIC ACID METHYL ESTER HYDROCHLORIDE is a white solid that is soluble in water and has a characteristic odor. It is commonly used in organic synthesis and drug development, as it can serve as a building block for the creation of more complex molecules. Additionally, it has potential applications in the field of pharmaceuticals and agrochemicals due to its unique chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 146117-95-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,1,1 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 146117-95:
(8*1)+(7*4)+(6*6)+(5*1)+(4*1)+(3*7)+(2*9)+(1*5)=125
125 % 10 = 5
So 146117-95-5 is a valid CAS Registry Number.
146117-95-5Relevant articles and documents
Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
-
, (2008/06/13)
The present invention relates to piperazine derivatives of the general formula STR1 in which Ra, Y1 to Y3 and E are defined herein, tautomers thereof, stereoisomers thereof, including their mixtures, and salts thereof, and in particular physiologically tolerated salts thereof with inorganic or organic acids or bases. These compounds have valuable pharmacological properties, such as aggregation-inhibiting activity. This invention also relates to medicaments comprising these compounds and to processes for the preparation of these compounds.
Amino acid derivatives
-
, (2008/06/13)
N-Acyl-α-aminocarboxylic acid derivatives of the formula STR1 wherein L, R' to R"' and Q have the significance given in the description, can be used for the treatment or control of illnesses which are caused by the binding of adhesive proteins to blood platelets and by blood platelet aggregation and cell-cell adhesion.